Meaghan Macrae
Adult Health · Middletown, RINPI 1457725731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Galderma Laboratories, L.p. at 33.2% of the total. Reporting peaked in 2022 at $326 and has fallen 64.5% since, to $116 in 2025.
Across 41 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$378
- AbbVie$297
- Exact Sciences$171
- Pfizer$163
- Biohaven Pharmaceutical Holding Company Ltd.$34
- Novo Nordisk$29
- plus $65 from 4 others
What the payments were for
- Food & beverage$1,13199%
- Education$61%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 6 | $378 |
| AbbVie | 9 | $297 |
| Exact Sciences | 8 | $171 |
| Pfizer | 10 | $163 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Novo Nordisk | 2 | $29 |
| GSK | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Covis Pharma GmbH | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$125
How this compares
$1,137 in reported general payments places this provider in the 75th percentile of 65 adult health providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $5,808 |
| NyamycNystatin | 13 | $1,002 |
| Atorvastatin Calcium | 83 | $878 |
| Diclofenac Sodium | 20 | $788 |
| Duloxetine Hcl | 19 | $702 |
| Methylphenidate Hcl | 14 | $576 |
| Lisinopril | 32 | $476 |
| Hydralazine Hcl | 13 | $472 |
| Pregabalin | 24 | $450 |
| Levothyroxine Sodium | 31 | $416 |
| ClopidogrelClopidogrel Bisulfate | 13 | $393 |
| Rosuvastatin Calcium | 17 | $378 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $376 |
| Omeprazole | 22 | $339 |
| Furosemide | 17 | $304 |
Paid to pharmacies, not to this prescriber.
Other adult health in Middletown
- Jacqueline AlbrikesJohnston$14K
- Elizabeth McGrathBarrington$7K
- Kathleen FranchinaWarwick$5K
- Deirdre CoutureCranston$5K
- Janine ZuromskiEast Greenwich$5K
- Christine UyProvidence$4K
- Kathleen RasslerEast Greenwich$3K
- Lindsay LeddyWarwick$3K
- Phina MayuProvidence$2K
- Joanne LowneyWarwick$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.